Performance and peptides: separating signaling from sports myth

Athletic performance sells certainty; endocrinology sells nuance. When conversation touches the growth-hormone axis, the tension between those cultures becomes obvious.

Tesamorelin (a GHRH analogue) and ipamorelin (a secretagogue) appear in literature with different designs and endpoints. Studies associated each with specific signals; neither authorizes a “guaranteed performance” slogan.

Preliminary findings and published clinical trials should be read with population, duration, and safety in view. Social-media testimonial shortcuts are not peer review.

From Asunción, this pillar invites coaches, curious athletes, and technical readers to demand method. EDGE VITAL catalogs these molecules as performance research—not competition talismans.

Useful questions: what did the study measure? Was there placebo? Which adverse events were reported? Does the sample resemble me? Without those questions, only marketing remains.

GH-axis science remains open: mechanisms, selectivity, clinical context. Celebrating published positives without hiding limits is the editorial line.

If you want to cross this map with the catalog, you can check Tesamorelin and Ipamorelin availability at EDGE VITAL Asunción and review the matching technical sheets.